Washington University School of Medicine: Depressive Disorder, Major trials
The registry lists 17 Depressive Disorder, Major studies with Washington University School of Medicine as lead sponsor. 2 are open to participants now and 11 have results posted.
Phase 1 3Phase 2 6Phase 4 3No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Nitrous Oxide- Suicidal IdeationEnrolling by invitationNCT03736538Phase 1
- NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain CircuitsRecruitingNCT02994433Phase 1
- Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing StrategiesCompletedNCT03283670Phase 2Results posted
- Stepped Care for Depression in Heart FailureCompletedNCT02997865Not applicableResults posted
- Optimizing Outcomes of Treatment-Resistant Depression in Older AdultsCompletedNCT02960763Phase 4Results posted
- Clinical Study of Generic and Brand Bupropion in DepressionCompletedNCT02209597Phase 4Results posted
- Buprenorphine Used With Treatment Resistant Depression in Older AdultsCompletedNCT02181231Phase 1/2Results posted
- Nitrous Oxide as Treatment for Major Depression - a Pilot StudyCompletedNCT02139540Phase 2Results posted
- A Randomized Controlled Trial of PCIT-ED for Preschool DepressionCompletedNCT02076425Not applicableResults posted
- Mommy-Baby Treatment for Perinatal DepressionCompletedNCT01744041Not applicableResults posted
- Repetitive Transcranial Magnetic Stimulation for Treating Depression: A Functional Magnetic Resonance Imaging StudyTerminatedNCT01162382Not applicableResults posted
- fMRI Study of Treatment Changes in Major DepressionCompletedNCT01027559Not applicableResults posted
- Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant DepressionCompletedNCT00953745Not applicableResults posted
- Psilocybin for Major Depressive DisorderWithdrawnNCT05675800Phase 2
- PET Synaptogenesis After Psilocybin In DEpression RecoveryWithdrawnNCT05601648Phase 2
- Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive DisorderTerminatedNCT03537547Phase 4
- fMRI-neuronavigated rTMS for the Treatment of Major Depression Associated With TBITerminatedNCT02980484Phase 2